Oliver Tait, Darley's chief operating officer, has resigned from the board of the Breeders' Cup following a board decision not to implement a ban on race-day medication for all championship races this year.
The West Virginia Racing Commission Feb. 26 approved a resolution agreeing in principle with the effort to bring uniform medication, penalty, and testing rules to racing jurisdictions in the Mid-Atlantic and Northeast.
The National Horsemen's Benevolent and Protective Association Medication Committee voted Feb. 23 to endorse the use of race-day furosemide, also called Salix or Lasix, at this year's Breeders' Cup World Championships.
Horsemen expect members of Congress to make another attempt at winning support for legislation that would regulate medication use in racehorses by banning all race-day administration.
The Maryland Racing Commission voted Feb. 19 to adopt a uniform equine medication, penalty, and testing program proposed for Thoroughbred and Standardbred racetracks throughout the Mid-Atlantic region.
The California Horse Racing Board will conduct its regular meeting Thursday, Feb. 21, at Santa Anita Park.
A search committee has been formed to find an equine veterinary medical director for the New York Racing Association.
Industry stakeholders, mostly from the Mid-Atlantic and Northeast, met Feb. 6 in Delaware to examine equine medication policy in an attempt to bring about uniformity from state to state.
A group of scientists met with representatives of the Thoroughbred Owners of California Jan. 18 to discuss exercise-induced pulmonary hemorrhaging and later issued a joint statement supporting use of furosemide.
Legislation calling for a ban on performance-enhancing drugs in horse racing has been sent to the New York Senate Racing, Gaming, and Wagering Committee.
New York racing regulators have amended rules, originally set to take effect Dec. 12, affecting the use of Clenbuterol and DempMedrol on Thoroughbred racehorses.
Racing jurisdictions and racetracks are making some headway on tightening the screws on integrity in the sport, though one official Dec. 6 described it as a "minefield" due to legal issues and court fights.
The $25,000 prize intended for three New York Times writers will instead benefit drug testing programs. The newspaper's editorial ethics policy prohibits the writers from accepting the award.
The use of racehorse medications and importance of owner education were among the topics discussed among trainers Kellyn Gorder, Tom Proctor, and Phil Sims at the Welfare and Safety of the Racehorse Summit at Keeneland.
Prodded by a rash of equine deaths at Aqueduct Racetrack last winter, the New York State Racing and Wagering Board Oct. 11 imposed what officials promised will be the first round of rules intended to make for safer racing.
New York racing officials are set to begin implementing new rules based on recommendations by a recent industry task force report to increase safety conditions for horses and jockeys.
Racing consultant Earl Ola talks about the relationship between conditioning and exercise-induced pulmonary hemorrhaging (EIPH), also known as bleeding read blog
A task force has determined the spate of fatal racehorse breakdowns at Aqueduct Racetrack this past winter was primarily the result of structural deficiencies in rules and regulations employed by NYRA and racing regulators.
Nearly two months have passed since a coalition of more than 60 owners launched an experiment into Salix-free racing, pledging to run their 2-year-olds without the controversial anti-bleeder medication read blog
R.D. Hubbard, chairman and majority owner of Ruidoso Downs in New Mexico, announced Sept. 3 that serious drug offenders will be banned from the race track's private property beginning in 2013.
The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.
Kentucky Gov. Steve Beshear Aug. 30 said regulations designed to reform some aspects of the state's equine medication policy will be implemented despite action by a legislative committee that found them deficient.
Two more national organizations have called on Kentucky to move forward with medication reform regulations shot down by a legislative committee Aug. 27.
Two national organizations said Aug. 28 they find it "troubling" factions in Kentucky horse racing are opposing medication regulations proposed by the Kentucky Horse Racing Commission but shot down by a legislative committee.
The West Virginia Racing Commission has officially scheduled a meeting for Sept. 17 to take comments from industry representatives on the use of furosemide, also known as Salix or Lasix, on race day.
A Kentucky legislative subcommittee, in a surprise vote, found regulations governing equine medication "deficient" Aug. 27, just one week before they are scheduled to take effect.
Furosemide will be the only medication permitted on race day in Kentucky effective Sept. 4, and the drug will be administered by regulatory veterinarians only under new Kentucky Horse Racing Commission rules.
The Nebraska Racing Commission is investigating a positive test for dermorphin, a Class 1 pain-killer more powerful than morphine.
The Jockey Club intends to continue with its efforts to market Thoroughbred racing and develop new patrons, but the organization's leader said Aug. 12 those efforts must go hand in hand with medication and penalty reforms.
In a change designed to win support of its Reformed Racing Medication Rules, The Jockey Club has added a provision governing regulatory administration of furosemide on race day.
There may be plenty of data out there on trainer performance, but for owners, selecting a conditioner involves much more than numbers, according to an owner and trainer that have worked together for about 15 years.
The West Virginia Racing Commission in late summer or early fall plans to hold a fact-finding meeting on use of furosemide on race day, officials said Aug. 4.
- By Tom LaMarra
The majority of National Horsemen's Benevolent and Protective Association affiliates have adopted resolutions calling for continued regulated use of furosemide on race day.
- By Tom LaMarra
A new grassroots organization that opposes use of medication on race day wants involvement by the federal government in horse racing.
Adding weight to horses racing on Salix would eliminate 'advantage' read blog
By Ned Bonnie, The horse industry has failed in its desire to prohibit the use of illegal drugs in horses. read blog
The industry is still short of the goal of uniformity from state to state read blog
Hollywood Casino at Penn National Race Course is the first of three Pennsylvania Thoroughbred tracks to require administration of race-day furosemide by third-party veterinarians.
In the wake of a New York Times article and an NBC Nightly News segment focused on injuries to I'll Have Another and the medications used to treat the Kentucky Derby and Preakness winner, Dr. Larry Bramlage issues a response.
The Association of Racing Commissioners International is reassessing its policy supporting race-day administration of furosemide, but also indicated much needs to be done before any change is made.
- By Tom LaMarra
A look back at some of the comments made during the July 12 medication hearing. read blog
The Jockey Club isn't opposed to federal regulation of medication and penalties in horse racing but it would prefer Congress not tinker with the Interstate Horse Racing Act, an organization official said July 12.
The Racing Medication and Testing Consortium has hired Dr. Dionne Benson as executive director and chief operating officer.
The Kentucky Horse Racing Commission said July 11 no dermorphin, a pain-killer more powerful than morphine, was found in samples tested from some horses that raced in this year's Derby and Oaks.
The U.S. Senate Committee on Commerce, Science, and Transportation has scheduled a hearing next week on "Medication and Performance Enhancing Drugs in Horse Racing."
Did you miss the live show? Listen now to the archived, on demand, version. Listen Now!
We should not be fooled into believing the New York Times is out to help racing. read blog
The National HBPA and its affiliates said they have "zero tolerance" for trainers who use illegal Class 1 and Class 2 substances in racehorses in the wake of about 30 positives for Dermorphin in the Southwest.
A new law that allows for an expansion of racetrack card clubs in Minnesota also permits the Minnesota Racing Commission to set threshold testing levels for therapeutic medications used in racehorses.
The board of directors of the Jockeys' Guild has voted to adopt 10 policy statements concerning race day medications and safety concerns.
Most Popular Stories
- Canterbury Releases 2014 Stakes Schedule
- American Gaming Association Adds Churchill
- Finger Lakes Launches ADW Site
- And They're Off: 2013 Offy Awards
- Flashback Likely Pick Among Malibu Probables
- Digging Deeper into Breeders' Cup Lasix Study
- Valenzuela Expects Healthy Santa Anita Meet
- Hangin' With Haskin: My Top 10 Racing Movies
- Native Diver Monument Moving to Del Mar
- Stretch Out No Problem for Unbeaten Samraat